TGF-β/SMAD signal transduction is a core pathophysiological pathway, responsible for inducing ECM deposition and repressing ECM degradation; thus, alterations in TGF-β/SMAD signaling might be crucial in AD pathogenesis [20]. The gene discussed is TGFB1; the disease is Alzheimer disease.